| BTAI Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BTAI market cap history going back to 3/8/2018:
Also see: BTAI Shares Outstanding History and BTAI YTD Return |
BTAI Market Cap History — BioXcel Therapeutics Capitalization Over Time
As of 5/14/2026 BioXcel Therapeutics has a market cap of 37.36 million. Investors often follow the BTAI market cap history to compare the size of the company over time.
This page shows BTAI market capitalization trends over time, with 32 market cap datapoints presented, dating back to 3/8/2018.
| BTAI Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BTAI Historical Market Cap: -16.75% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BTAI Stock Price Chart |
| About BioXcel Therapeutics Inc |
| BioXcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence to develop medicines in neuroscience and immuno-oncology through its subsidiary, OnkosXcel Therapeutics. Co.'s neuroscience candidate, BXCL501, is an investigational, orally dissolving film for treating agitation in psychiatric and neurological disorders, including bipolar disorders, schizophrenia and Alzheimer's-related dementia, for both at-home and care facility settings. Co.'s immuno-oncology candidate, BXCL701, is an oral innate immune activator aimed at treating aggressive prostate cancer, pancreatic cancer and other solid and liquid tumors. We show 32 historical shares outstanding datapoints in our BTAI shares outstanding history coverage, used to compute BTAI market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BTAI market cap history over the course of time is important for investors interested in comparing BTAI's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BTAI versus a peer is one thing; comparing BTAI market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BTAI can fluctuate over the course of history. With this page we aim to empower investors researching BTAI by allowing them to research the BTAI market cap history. |
| BTAI Current Stock Quote |
Quotes delayed 20 minutes  Free BTAI Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| BTAI Share Performance |
| Market Cap Peers |
| BioXcel Therapeutics (BTAI) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
BTCY Market Cap History BTSG Market Cap History BUG Market Cap History BUR Market Cap History BVS Market Cap History BWV Market Cap History BXRX Market Cap History CABA Market Cap History CADL Market Cap History CAH Market Cap History More Healthcare companies » |
BTAI Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
